Fmoc-D-phenylglycine is a protected, non-natural amino acid derivative featuring a D-phenylglycine backbone bearing a benzyl-like side chain and an N-(9H-fluoren-9-ylmethoxycarbonyl) (Fmoc) protecting group on the amino functionality. The molecule contains a free carboxylic acid for coupling and an Fmoc carbamate that masks the amino group, with stereochemistry specified as the D configuration at the alpha carbon. Fmoc-D-phenylglycine is employed as a building block in stepwise peptide synthesis workflows, including solid-phase peptide synthesis, where the protected amine and carboxyl group enable controlled formation of amide bonds to introduce the phenylglycine residue into peptide sequences.
CAT No: CP09706
CAS No:111524-95-9
Synonyms/Alias:Fmoc-D-Phg-OH;111524-95-9;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylaceticacid;Fmoc-D-Phenylglycine;Fmoc-D-alpha-phenylglycine;Fmoc-L-|A-Phenylglycine;ST51037462;(R)-[(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)]-PHENYL-ACETICACID;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-phenyl-aceticacid;(2R)-([(9H-FLUOREN-9-YL-METHOXY)CARBONYL]AMINO)(PHENYL)ACETICACID;(2R)-{[(9H-Fluoren-9-Yl-Methoxy)Carbonyl]Amino}(Phenyl)AceticAcid;AC1MBSTC;FMOC-D-A-PHENYLGLYCINE;SCHEMBL118281;AC1Q71D5;00211_FLUKA;(R)-N-FMOC-PHENYLGLYCINE;FMOC-D-PHENYLGLYCINEAMIDE;MolPort-003-725-671;PCJHOCNJLMFYCV-OAQYLSRUSA-N;ZINC4521085;N-ALPHA-FMOC-D-PHENYLGLYCINE;ANW-75220;CF-295;MFCD00190891
Fmoc-D-phenylglycine is a chiral, N-(9H-fluoren-9-ylmethoxycarbonyl) protected amino acid derivative in which the D-stereocenter is retained at the alpha-carbon adjacent to a phenylglycine side chain. The molecule contains an Fmoc carbamate that masks the amino functionality for controlled peptide coupling, alongside a carboxylic acid handle suitable for amide bond formation after activation. Aromatic character from the benzyl-like phenyl side group and the stereodefined backbone can influence conformational preferences and coupling outcomes in peptide and peptidomimetic scaffolds. The protected amino acid format also supports orthogonal deprotection strategies commonly used in solid-phase and solution-phase synthesis, making it a practical chiral intermediate for downstream functionalization.
1. Peptide Synthesis
Fmoc-D-phenylglycine is used in peptide synthesis workflows where Fmoc protection enables stepwise N-terminal assembly while the carboxylic acid participates in standard peptide coupling chemistry. The D-configuration at the alpha-carbon provides stereochemical control for incorporating D-amino acid residues into peptides, which can modulate backbone geometry and proteolytic stability in constructed sequences. The phenylglycine side chain contributes aromatic bulk that can be leveraged for hydrophobic interactions within peptide libraries and for tuning folding motifs in synthetic constructs. The resulting peptidic products can be generated for structure-activity relationship studies and for producing D-amino acid containing peptide building blocks that remain compatible with routine deprotection and chain extension cycles.
2. Peptidomimetics And SAR
Fmoc-D-phenylglycine is applied in peptidomimetic construction and SAR studies because the Fmoc-protected amino acid serves as a stereochemically defined chiral unit for installing a phenylglycine motif into bioactive-like scaffolds. The combination of an aromatic side chain and the D-amino acid backbone can be used to probe how steric and stereoelectronic effects influence molecular recognition, including changes in conformational bias and side-chain orientation. Fmoc deprotection and subsequent coupling allow rapid generation of analog series where the phenylglycine residue is systematically varied in position or neighboring residues. Downstream derivatives prepared from the coupled products can feed medicinal chemistry programs focused on mapping structure-function relationships of peptide-like ligands.
3. Chiral Building Block Synthesis
Fmoc-D-phenylglycine is employed as a chiral amino acid intermediate for stereoselective synthesis of D-phenylglycine-containing fragments used in synthetic organic chemistry and medicinal chemistry intermediate preparation. The preserved D-stereocenter and the protected amine reduce the risk of racemization during peptide bond formation steps, supporting reproducible construction of chiral amide linkages. The carboxylic acid functionality can be activated for coupling to diverse amines, enabling access to N-substituted derivatives and amide-containing intermediates beyond peptides. The Fmoc group also provides a handle for orthogonal manipulation, supporting downstream transformations such as conversion to alternative protected forms when building larger chiral scaffolds.
4. Side-Chain Functionalization
Fmoc-D-phenylglycine is suitable for side-chain functionalization strategies in chemical biology and synthetic methodology development where the phenylglycine aromatic motif can be further elaborated after incorporation into a target framework. The Fmoc-protected amino acid format supports controlled assembly into intermediates that can later be deprotected to expose reactive amino termini for conjugation or further derivatization. The aromatic side chain can participate in electrophilic aromatic substitution, cross-coupling, or oxidative modifications depending on the downstream synthetic design, enabling generation of labeled or affinity-tagged analogs. Constructed intermediates can then be used to access functionalized peptide analogs, aromatic-rich conjugates, and chiral building blocks for studying molecular interactions.
5. Chemical Biology Labeling
Fmoc-D-phenylglycine is applied in chemical biology labeling and biomolecule modification workflows where D-amino acid incorporation can improve stability of labeled peptide probes or recognition elements. The Fmoc-protected amino acid enables controlled placement of a stereodefined D-residue within peptide tags that can be subsequently deprotected and coupled to targeting ligands or reporter moieties. The phenylglycine aromatic group can serve as a scaffold for attaching fluorescent, affinity, or mass-tag functionalities through downstream derivatization of aromatic substituents or through coupling of activated carboxyl-derived intermediates. The resulting labeled constructs can be used as research reagents for mapping binding interactions, tracking synthetic peptides, and generating stable probe libraries compatible with peptide chemistry operations.
6. Pharmaceutical Intermediate Preparation
Fmoc-D-phenylglycine is utilized in pharmaceutical intermediate preparation and process chemistry contexts as a protected amino acid building block for manufacturing peptide-like intermediates used in fine chemical production. The Fmoc carbamate provides a protected N-terminus that can be removed under standard deprotection conditions, enabling reliable conversion into reactive amino intermediates for subsequent coupling steps in controlled synthetic sequences. The stereodefined D-phenylglycine residue supports reproducible assembly of chiral amide linkages that are relevant to producing D-amino acid containing peptide analogs and peptidomimetic intermediates. The compound's protected amino acid structure also aligns with scalable chiral synthesis practices where orthogonal protection and predictable coupling behavior are required for downstream synthetic route design.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.